US Conference on Rare Diseases & Orphan Products: Shaping the Future Now

Register by October 1 to Save US Conference on Rare Diseases & Orphan Products: Shaping the Future Now October 22-24 | Washington, DC Co-sponsored by NORD Register by October 1 to Save! The US Conference on Rare Diseases and Orphan Products features keynote presentations, high-level plenary and smaller group sessions, including comprehensive coverage of today's hottest topics in sessions intended to promote advancements in science, care, and other considerations that will address the needs of the 30 million Americans with rare diseases.  Day 2 Keynote Speaker: Stephen P. Spielberg, MD, PhD Deputy Commissioner, Medical Products and Tobacco Office of the Commissioner Food and Drug Administration Featured Session Topics:      • Access and Reimbursement      • Challenges of Reimbursement for the Rare Disease Patient      • Comparative Effectiveness Research and Health Technology Assessments (HTA)      • Facing the Crisis in Biomedical Innovation: A Venture Investor’s Perspective      • Impact of FDASIA on Orphan Product Development      • Investing in Orphan Products: Is the Environment getting Better Or Worse      • Natural History Studies      • New Relationship with the Patient Community – FDA and the Patient      • New Relationship with the Patient Community – Industry and the Patient      • NIH Updates      • Postmarketing Period-Opportunities for Continued Learning      • Shaping the Future of Health Policy Now      • Working with the FDA   Program Overview Table Top Exhibit Opportunities: Showcase your company's products and services. Submit your application today to Shannon Lewis. Special Offer: Register for both US Conference on Rare Diseases & Orphan Products and Clinical Trial Endpoints: Methods and Practice in Developing Measurements – and Save Up to $500!*  Stay Connected with DIA One-Day Interactive Workshop with a Special Emphasis on Rare Diseases Clinical Trial Endpoints: Methods and Practice in Developing Measurements October 25 | Washington, DC This one-day interactive workshop with special emphasis on rare diseases will provide a detailed examination of the process for developing, validating, and implementing patient-focused clinical trial outcome measures that will meet regulatory requirements for adequate and well-controlled clinical trials, product approval, and labeling. Register by October 4 to Save!   Program Overview | Register Now *Offer expires October 1 and only applicable to the Industry rate. You must register for both events at the same time. Already registered for one of these events? Contact Customer Service

DIA Worldwide Headquarters
800 Enterprise Road, Suite 200
Horsham, Pennsylvania 19044-3595
T. +1.215.442.6100
F. +1.215.442.6199